StoxVaishali Pharma Limited
NSE: VAISHALI · Unclassified
Ask the data
Instant answers about Vaishali Pharma Limited — computed from its filings, no language modelPrice & valuation
split & bonus adjusted · pick a metric and rangeAnnual performance
annual · ₹ crore · line = operating margin| FY26 | |
|---|---|
| Revenue | 108.8 |
| EBITDA | 4.1 |
| Operating margin | 3.8% |
| Interest | 2.0 |
| Depreciation | 0.6 |
| Profit before tax | 5.4 |
| Tax | 1.4 |
| Net profit | 4.2 |
| EPS ₹ | 0.32 |
| Operating cash flow | 0.4 |
| Capex | 0.5 |
| Dividend paid | 0.0 |
| Total assets | 123.4 |
| Equity | 69.1 |
Quarterly performance
last 4 quarters · ₹ crore| SEP '25 | DEC '25 | MAR '26 | JUN '26 | |
|---|---|---|---|---|
| Revenue | 33.5 | 24.6 | 26.9 | 22.9 |
| Operating profit | 1.4 | 1.6 | -0.2 | 1.5 |
| Operating margin | 4.2% | 6.3% | -0.7% | 6.5% |
| Other income | 0.8 | 0.9 | 1.3 | 0.6 |
| Interest | 0.4 | 0.5 | 0.7 | 0.2 |
| Depreciation | 0.2 | 0.1 | 0.2 | 0.1 |
| Profit before tax | 1.7 | 1.8 | 0.2 | 1.7 |
| Tax | 0.5 | 0.5 | -0.1 | 0.2 |
| Net profit | 1.2 | 1.3 | 0.4 | 1.6 |
| EPS ₹ | 0.09 | 0.10 | 0.03 | 0.12 |
Returns & margins
trailing-twelve-month, per quarter| JUN '26 | |
|---|---|
| ROE | 6.4% |
| ROCE | 8.2% |
| Net margin | 4.1% |
| EBITDA margin | 3.9% |
| Debt / equity | 0.27 |
| Interest coverage | 3.95 |
| Asset turnover | 0.87 |
Balance sheet
equity vs borrowings over time · ₹ crore| SEP '25 | MAR '26 | |
|---|---|---|
| Share capital | 26.1 | 26.1 |
| Other equity / reserves | 41.3 | 43.0 |
| Total equity | 67.4 | 69.1 |
| Borrowings | 15.1 | 18.5 |
| Current liabilities | 47.0 | 48.3 |
| Non-current liabilities | 7.5 | 6.0 |
| Total assets | 121.9 | 123.4 |
| Property, plant & equipment | 1.0 | 0.9 |
| Capital work-in-progress | 0.0 | — |
| Investments | 5.4 | 5.6 |
| Inventories | 1.9 | 3.4 |
| Receivables | 51.2 | 50.8 |
| Cash & equivalents | 0.8 | 1.1 |
Cash flow
annual · ₹ crore · line = free cash flow| FY26 | |
|---|---|
| Cash from operations | 0.4 |
| Cash from investing | -5.5 |
| Cash from financing | 4.6 |
| Capex | 0.5 |
| Free cash flow | -0.0 |
| Dividends paid | 0.0 |
Where the assets sit
Mar '26 · ₹ crorePeer comparison
largest in Unclassified · this company in bold| Company | Market cap ₹cr | Price | P/E | P/B | ROE |
|---|---|---|---|---|---|
| Avantel Limited | 36,86,04,549 | 138.69 | — | 1059360.68 | 0.0% |
| Ducol Organics And Colours Limited | 19,55,275 | 120.00 | — | 20089.13 | 0.0% |
| Jio Platforms Limited | 12,57,181 | 1,406.40 | — | 3.57 | — |
| SBI Funds Management Limited | 1,01,750 | 499.55 | — | — | — |
| Tamilnadu Telecommunication Limited | 91,314 | 9.93 | — | — | — |
| Manipal Health Enterprises Limited | 76,294 | 646.70 | — | — | — |
| INDO-MIM Limited | 59,042 | 1,219.50 | — | — | — |
| AvenuesAI Limited | 45,138 | 129.25 | 153.6 | 9.51 | 6.2% |
| Dhoot Transmission Limited | 32,761 | 1,601.60 | — | 8.11 | — |
| 3M India Limited | 31,071 | 27,570.00 | 53.8 | 17.57 | 32.7% |
| Vaishali Pharma Limited | 44 | 6.76 | 9.9 | 0.64 | 6.4% |
StoxGud checklist: Bearish setup · 3/10
- Price above 50-day average
- Price above 200-day average
- 50-day average above 200-day (uptrend)
- RSI in healthy 40–70 zone
- Positive 1-year return
- Return on equity above 15%
- Debt to equity below 1
- Revenue growing year on year
- Net profit margin above 10%
- P/E below industry median
A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.
Returns & technicals
FAQs
What is the share price of Vaishali Pharma Limited?
Vaishali Pharma Limited (VAISHALI) closed at ₹6.76 on NSE on 06 Nov 2026.
What is the market cap of Vaishali Pharma Limited?
₹44 crore at the latest close.
What is the P/E ratio of Vaishali Pharma Limited?
9.9, on trailing-twelve-month earnings from its filings.
How fast is Vaishali Pharma Limited growing?
Not enough filed history yet to measure Vaishali Pharma Limited's growth.
How profitable is Vaishali Pharma Limited?
On a trailing-twelve-month basis return on equity is 6.4%, return on capital employed 8.2%, operating margin 3.9%, net margin 4.1%.
How much debt does Vaishali Pharma Limited have?
Vaishali Pharma Limited is lightly geared: debt to equity is 0.27 with borrowings of ₹19 cr against cash of ₹1 cr (balance sheet of 2026-03-31). Operating profit covers interest 3.9 times.
Financials parsed from Vaishali Pharma Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from SEP '25, annual from FY26, balance sheet from Sep '25. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.